[Thromboembolytic complications. Alternative anticoagulation in HIT II].
D000925:Anticoagulants / Q000627:therapeutic use*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D003422:Critical Care; D003871:Dermatan Sulfate / Q000627:therapeutic use*; D004338:Drug Combinations; D006497:Heparan Sulfate / Q000627:therapeutic use*; D006801:Humans; D013921:Thrombocytopenia / Q000188:drug therapy*
D000925:Anticoagulants; D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D004338:Drug Combinations; D006497:Heparan Sulfate; C035838:danaparoid
Thromboembolie-Komplikationen. Alternative Antikoagulation bei HIT II.